|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.03 USD | +3.23% |
|
+6.29% | -20.02% |
| 05-16 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
| Market Cap | 1.2B 1.05B 964M 899M 1.7B 114B 1.73B 11.6B 4.5B 56.08B 4.51B 4.41B 193B | P/E 2026 * |
13.9x | P/E 2027 * | 9.93x |
|---|---|---|---|---|---|
| Enterprise Value | 1.95B 1.71B 1.57B 1.46B 2.77B 186B 2.82B 18.86B 7.31B 91.14B 7.33B 7.17B 314B | EV / Sales 2026 * |
2.23x | EV / Sales 2027 * | 1.73x |
| Free-Float |
77.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Collegium Pharmaceutical, Inc.
| 1 day | +3.23% | ||
| 1 week | +6.29% | ||
| Current month | +2.29% | ||
| 1 month | +21.49% | ||
| 3 months | +14.61% | ||
| 6 months | -18.67% | ||
| Current year | -20.02% |
| 1 week | 35.17 |  | 37.42 |
| 1 month | 31.61 | | 37.42 |
| Current year | 30.13 | | 49.31 |
| 1 year | 29.19 | | 50.79 |
| 3 years | 20.83 | | 50.79 |
| 5 years | 14.04 | | 50.79 |
| 10 years | 7.37 | | 50.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikram Karnani
CEO | Chief Executive Officer | 51 | 12/11/2024 |
Colleen Tupper
DFI | Director of Finance/CFO | 50 | 24/05/2021 |
Thomas Smith
CTO | Chief Tech/Sci/R&D Officer | 65 | 23/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gino Santini
CHM | Chairman | 69 | 15/05/2025 |
John Freund
BRD | Director/Board Member | 72 | 01/02/2014 |
Garen Bohlin
BRD | Director/Board Member | 78 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-08 | Fiscal year | Chairman | 17,400 | 0.0536% | ||
| 05-18 | Sell | Director | -20 | 0.0001% | ||
| 05-15 | Fiscal year | Director | 21,527 | 0.0664% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.23% | +6.29% | +21.37% | +72.31% | 1.2B | |
| +3.45% | +7.65% | +55.77% | +158.84% | 1,082B | |
| -1.16% | +7.42% | +69.09% | +58.92% | 633B | |
| -0.77% | +7.37% | +36.87% | +93.77% | 461B | |
| -0.35% | +1.85% | +31.30% | +24.86% | 339B | |
| -0.56% | +1.17% | +41.96% | +39.64% | 301B | |
| -0.08% | +1.49% | +32.40% | +44.75% | 292B | |
| -1.54% | +2.58% | -25.52% | -39.75% | 225B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 202B | |
| +0.40% | +6.00% | +17.72% | +70.33% | 163B | |
| Average | +1.66% | +2.20% | +30.70% | +59.22% | 370.09B | |
| Weighted average by Cap. | +1.37% | +1.96% | +42.23% | +81.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 875M 764M 702M 654M 1.24B 83.26B 1.26B 8.45B 3.27B 40.84B 3.28B 3.21B 141B | 886M 774M 711M 663M 1.26B 84.33B 1.28B 8.56B 3.32B 41.36B 3.33B 3.25B 143B |
| Net income | 108M 94.57M 86.84M 80.98M 154M 10.3B 156M 1.05B 405M 5.05B 406M 398M 17.41B | 158M 138M 127M 118M 225M 15.07B 228M 1.53B 593M 7.39B 594M 581M 25.47B |
| Net Debt | 751M 656M 602M 562M 1.07B 71.48B 1.08B 7.25B 2.81B 35.06B 2.82B 2.76B 121B | 328M 286M 263M 245M 465M 31.2B 473M 3.17B 1.23B 15.3B 1.23B 1.2B 52.73B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | US$37.03 | +3.23% | 480,480 |
| 01/07/26 | US$35.87 | -0.91% | 405,897 |
| 30/06/26 | US$36.20 | +0.61% | 357,582 |
| 29/06/26 | US$35.98 | -1.67% | 510,870 |
| 26/06/26 | US$36.59 | +5.02% | 1,618,507 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COLL Stock
Select your edition
All financial news and data tailored to specific country editions
